The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma

Abstract Background Epidermal growth factor receptor (EGFR) mutations were frequently found with concomitant genetic alterations in lung adenocarcinoma (LUAD). This study aimed to investigate the profile of concomitant alterations of EGFR‐mutant LUAD ≤3 cm in size and its prognostic effect on recurr...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Wensheng Zhou, Zhichao Liu, Yanan Wang, Yanwei Zhang, Fangfei Qian, Jun Lu, Huimin Wang, Ping Gu, Minjuan Hu, Ya Chen, Zhengyu Yang, Ruiying Zhao, Yuqing Lou, Baohui Han, Wei Zhang
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Subjects:	concomitant mutation EGFR lung adenocarcinoma recurrence‐free survival
Online Access:	https://doi.org/10.1002/cam4.4543